EU regulator backs approval for GSK injectable asthma drug – Yahoo News


Yahoo News

EU regulator backs approval for GSK injectable asthma drug
Yahoo News
The treatment could help boost GSK's respiratory drugs business as demand weakens for its asthma drug, Advair. A significant minority of asthma patients do not respond to regular inhalers such as Advair, Dulera and Flovent, creating what analysts
Glaxo asthma drug clears key hurdle in EuropeMarketWatch
CHMP Backs Mepolizumab for Severe Eosinophilic AsthmaMedscape
GlaxoSmithKline's asthma injection heads for EU approvalFierceBiotech
Bidness ETC
all 32 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.